Genentech’s earnings soared 89%in the second quarter...
- Share via
Genentech’s earnings soared 89%in the second quarter to $5.3 million. The South San Francisco biotechnology company said its sales of Protropin brand of pharmaceuticals increased 111% from the year-ago period. Latest quarter income included an extraordinary item related to a tax-loss carryforward.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
